XML 41 R23.htm IDEA: XBRL DOCUMENT
v3.3.1.900

OPERATING BUSINESS SEGMENT AND INTERNATIONAL OPERATION INFORMATION | 12 Months Ended
--- | ---
Dec. 31, 2015
Segment Reporting [Abstract] |
OPERATING BUSINESS SEGMENT AND INTERNATIONAL OPERATION INFORMATION | OPERATING BUSINESS SEGMENT AND INTERNATIONAL OPERATION INFORMATION The Company has four business segments. These business segments are components of the Company for which separate information is available that is evaluated regularly by the chief executive officer in deciding how to allocate resources and in assessing relative performance. The Company has two business segments that operate under the Nature’s Sunshine® Products brand and are divided based on the characteristics of their Distributor base, similarities in compensation plans, as well as the internal organization of NSP’s officers and their responsibilities (NSP Americas and NSP Russia, Central and Eastern Europe). The Company’s third business segment operates under the Synergy® WorldWide brand, which distributes its products through different selling and Distributor compensation plans and has products with formulations that are sufficiently different from those of NSP Americas and NSP Russia, Central and Eastern Europe to warrant accounting for these operations as a separate business segment. The Company’s fourth business segment, China and New Markets, anticipates deploying a multi-brand, multi-channel go-to-market strategy that offers select Nature’s Sunshine branded products through Fosun Pharma’s retail locations across China as well as ecommerce, and select Synergy branded products through a direct selling model. The time to market will be dependent upon regulatory processes including product registration and permit approvals. Due to a change in the Chinese regulatory environment, the Company has indefinitely deferred its entry into the retail channel. The China and New Markets segment also includes Company’s export sales business, in which the Company sells its products to various locally managed entities independent of the Company that have distribution rights for the relevant market. All of the net sales revenue to date in the China and New Markets segment is through the Company’s export business to foreign markets outside of China set forth above that were previously part of NSP Americas. Net sales revenues for each segment have been reduced by intercompany sales as they are not included in the measure of segment profit or loss reviewed by the chief executive officer. The Company evaluates performance based on contribution margin (loss) by segment before consideration of certain inter-segment transfers and expenses. In the fourth quarter of 2014, the Company created the China and New Markets segment. The Company moved the reporting of its wholesale business, in which the Company sells its products to a locally managed entity independent of the Company that has distribution rights for the market, from the NSP Americas segment to the China and New Markets segment during the year ended December 31, 2014, as well as the results of its NSP Peru and United Kingdom markets, which were converted to wholesale markets during the prior year. The net sales revenue and contribution margin of this business for the year ended December 31, 2015 were $4.1 million and $1.9 million, respectively. The net sales revenue and contribution margin of this business for the year ended December 31, 2014 were $5.6 million and $2.6 million, respectively. The net sales revenue and contribution margin of this business for the year ended December 31, 2013 were $8.1 million and $3.2 million, respectively. Reportable business segment information for the years ended December 31, 2015, 2014, and 2013 is as follows (dollar amounts in thousands):
Year Ended December 31, |  | 2015 |  | 2014 |  | 2013
Net sales revenue: |  |  |  |  |  |  |  |  |
NSP Americas |  | $ | 179,151 |  |  | $ | 182,395 |  |  | $ | 190,684 |
NSP Russia, Central and Eastern Europe |  | 27,408 |  |  | 50,274 |  |  | 62,747 |
Synergy WorldWide |  | 114,081 |  |  | 128,101 |  |  | 108,290 |
China and New Markets |  | 4,065 |  |  | 5,597 |  |  | 8,105 |
Total net sales revenue |  | 324,705 |  |  | 366,367 |  |  | 369,826 |
Contribution margin (1): |  |  |  |  |  |  |  |  |
NSP Americas |  | 74,953 |  |  | 74,603 |  |  | 78,171 |
NSP Russia, Central and Eastern Europe |  | 9,474 |  |  | 17,851 |  |  | 22,542 |
Synergy WorldWide |  | 35,277 |  |  | 43,888 |  |  | 38,011 |
China and New Markets |  | 1,870 |  |  | 2,633 |  |  | 3,242 |
Total contribution margin |  | 121,574 |  |  | 138,975 |  |  | 141,966 |
Selling, general and administrative |  | 107,702 |  |  | 119,927 |  |  | 118,383 |
Operating income |  | 13,872 |  |  | 19,048 |  |  | 23,583 |
Other income (loss), net |  | (592 | ) |  | (34 | ) |  | 1,993 |
Income from continuing operations before provision for income taxes |  | $ | 13,280 |  |  | $ | 19,014 |  |  | $ | 25,576 |
___________________________ (1) Contribution margin consists of net sales revenue less cost of sales and volume incentives expense.
Year Ended December 31, |  | 2015 |  | 2014 |  | 2013
Capital expenditures: |  |  |  |  |  |  |  |  |
NSP Americas |  | $ | 21,437 |  |  | $ | 25,581 |  |  | $ | 8,018 |
NSP Russia, Central and Eastern Europe |  | — |  |  | 8 |  |  | 4 |
Synergy WorldWide |  | 302 |  |  | 1,321 |  |  | 534 |
China and New Markets |  | 487 |  |  | — |  |  | — |
Total capital expenditures |  | $ | 22,226 |  |  | $ | 26,910 |  |  | $ | 8,556 |
Depreciation and amortization: |  |  |  |  |  |  |  |  |
NSP Americas |  | $ | 3,603 |  |  | $ | 3,438 |  |  | $ | 3,568 |
NSP Russia, Central and Eastern Europe |  | 26 |  |  | 25 |  |  | 27 |
Synergy WorldWide |  | 885 |  |  | 946 |  |  | 871 |
China and New Markets |  | 11 |  |  | — |  |  | — |
Total depreciation and amortization |  | $ | 4,525 |  |  | $ | 4,409 |  |  | $ | 4,466 |
As of December 31, |  | 2015 |  | 2014
Assets: |  |  |  |  |  |
NSP Americas |  | $ | 141,428 |  |  | $ | 129,371 |
NSP Russia, Central and Eastern Europe |  | 5,122 |  |  | 6,679 |
Synergy WorldWide |  | 38,048 |  |  | 40,797 |
China and New Markets |  | 15,922 |  |  | 19,952 |
Total assets |  | $ | 200,520 |  |  | $ | 196,799 |
From an individual country perspective, only the United States and South Korea comprises approximately 10 percent or more of consolidated net sales revenue for any of the years ended December 31, 2015, 2014, and 2013 as follows (dollar amounts in thousands):
Year Ended December 31, |  | 2015 |  | 2014 |  | 2013
Net sales revenue: |  |  |  |  |  |  |  |  |
United States |  | $ | 147,553 |  |  | $ | 148,219 |  |  | $ | 152,209 |
South Korea |  | 48,476 |  |  | 54,314 |  |  | 34,207 |
Other |  | 128,676 |  |  | 163,834 |  |  | 183,410 |
Total net sales revenue |  | $ | 324,705 |  |  | $ | 366,367 |  |  | $ | 369,826 |
Revenue generated by each of the Company’s product lines is set forth below (dollars in thousands):
Year Ended December 31, |  | 2015 |  | 2014 |  | 2013
NSP Americas: |  |  |  |  |  |  |  |  |
General health |  | $ | 80,315 |  |  | $ | 78,218 |  |  | $ | 80,379 |
Immunity |  | 22,042 |  |  | 23,549 |  |  | 23,374 |
Cardiovascular |  | 12,331 |  |  | 12,566 |  |  | 13,018 |
Digestive |  | 49,239 |  |  | 53,133 |  |  | 55,936 |
Personal care |  | 3,575 |  |  | 4,000 |  |  | 5,162 |
Weight management |  | 11,649 |  |  | 10,929 |  |  | 12,815 |
|  | 179,151 |  |  | 182,395 |  |  | 190,684 |
NSP Russia, Central and Eastern Europe: |  |  |  |  |  |  |  |  |
General health |  | $ | 11,433 |  |  | $ | 18,841 |  |  | $ | 22,690 |
Immunity |  | 3,328 |  |  | 6,512 |  |  | 7,902 |
Cardiovascular |  | 1,714 |  |  | 3,104 |  |  | 4,324 |
Digestive |  | 7,167 |  |  | 13,171 |  |  | 15,693 |
Personal care |  | 2,716 |  |  | 6,073 |  |  | 8,817 |
Weight management |  | 1,050 |  |  | 2,573 |  |  | 3,321 |
|  | 27,408 |  |  | 50,274 |  |  | 62,747 |
Synergy WorldWide: |  |  |  |  |  |  |  |  |
General health |  | $ | 43,829 |  |  | $ | 46,546 |  |  | $ | 36,723 |
Immunity |  | 752 |  |  | 974 |  |  | 1,394 |
Cardiovascular |  | 34,191 |  |  | 42,449 |  |  | 42,154 |
Digestive |  | 17,746 |  |  | 20,839 |  |  | 16,897 |
Personal care |  | 5,697 |  |  | 7,196 |  |  | 7,097 |
Weight management |  | 11,866 |  |  | 10,097 |  |  | 4,025 |
|  | 114,081 |  |  | 128,101 |  |  | 108,290 |
China and New Markets: |  |  |  |  |  |  |  |  |
General health |  | $ | 1,903 |  |  | $ | 2,370 |  |  | $ | 3,259 |
Immunity |  | 525 |  |  | 777 |  |  | 1,006 |
Cardiovascular |  | 292 |  |  | 334 |  |  | 461 |
Digestive |  | 1,011 |  |  | 1,608 |  |  | 2,365 |
Personal care |  | 93 |  |  | 108 |  |  | 126 |
Weight management |  | 241 |  |  | 400 |  |  | 888 |
|  | 4,065 |  |  | 5,597 |  |  | 8,105 |
Total net sales revenue |  | $ | 324,705 |  |  | $ | 366,367 |  |  | $ | 369,826 |
From an individual country perspective, only the United States comprise 10 percent or more of consolidated property, plant and equipment as follows (dollar amounts in thousands):
As of December 31 |  | 2015 |  | 2014
Property, plant and equipment |  |  |  |  |  |
United States |  | $ | 66,044 |  |  | $ | 48,013 |
Other |  | 2,684 |  |  | 3,330 |
Total property, plant and equipment |  | $ | 68,728 |  |  | $ | 51,343 |
Due to the continual currency devaluation of the Venezuelan bolivar, as of September 30, 2014, the Company incurred a $2.9 million impairment charge to write down the value of its fixed assets in Venezuela to $0.

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 34 -URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8981-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9038-108599 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 33 -URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8971-108599 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8595-108599 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8380-108599 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8933-108599 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8844-108599 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 35 -URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8984-108599 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9031-108599 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9054-108599 Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8538-108599 Reference 12: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 29 -URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8864-108599 Reference 13: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8924-108599 Reference 14: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8906-108599 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration